Who
Cynthia M. Butitta
Director
Company insider
Files Form 4 as: Director, Autolus Therapeutics; Director, UroGen Pharma; Director, Olema Pharmaceuticals; Director, Century Therapeutics; Chief Operating Officer, Kite Pharma; COO and CFO, Telik.
In numbers
- Trades disclosed
- 204
- Buys
- 1
- Sells
- 36
- Bought
- $77K
- Sold
- $25.8M
- Companies
- 6
- Companies where not an officer
- 4
- First trade
- 10 Mar 2006
- Last trade
- 29 Jun 2026
- Last filed
- 1 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Jun 2026filed 1 Jul 2026 | AUTL Autolus Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —31,667 at $0.00 | filing |
| 29 Jun 2026filed 1 Jul 2026 | AUTL Autolus Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —47,500 at $0.00 | filing |
| 29 Jun 2026filed 1 Jul 2026 | AUTL Autolus Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —31,667 at $0.00 | filing |
| 29 Jun 2026filed 1 Jul 2026 | AUTL Autolus Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —47,500 at $0.00 | filing |
| 22 Jun 2026filed 24 Jun 2026 | URGN UroGen Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 22 Jun 2026filed 24 Jun 2026 | URGN UroGen Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,000 at $0.00 | filing |
| 22 Jun 2026filed 24 Jun 2026 | URGN UroGen Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 22 Jun 2026filed 24 Jun 2026 | URGN UroGen Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,000 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,500 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,500 at $0.00 | filing |
| 26 Nov 2025filed 1 Dec 2025 | URGN UroGen Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,000 at $0.00 | filing |
| 26 Nov 2025filed 1 Dec 2025 | URGN UroGen PharmaBiotechnology | SEC FORM 4 Code M | —2,000 | filing |
| 26 Aug 2025filed 27 Aug 2025 | URGN UroGen Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 26 Aug 2025filed 27 Aug 2025 | URGN UroGen Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,000 at $0.00 | filing |
| 12 Jun 2025filed 16 Jun 2025 | IPSC Century Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,000 at $0.00 | filing |
| 11 Jun 2025filed 13 Jun 2025 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,150 at $0.00 | filing |
| 6 Aug 2024filed 8 Aug 2024 | URGN UroGen Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 20 Jun 2024filed 21 Jun 2024 | IPSC Century Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,000 at $0.00 | filing |
| 14 Jun 2024filed 18 Jun 2024 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —23,000 at $0.00 | filing |
| 7 Sep 2023filed 8 Sep 2023 | URGN UroGen Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.